Resolute Advisors’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,000
Closed -$111K 143
2022
Q3
$111K Hold
40,000
0.01% 61
2022
Q2
$49K Buy
+40,000
New +$67.1K 0.01% 72

Resolute Advisors's ZY Position: Q4 2022 in Review

Resolute Advisors sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 40,000 shares — an estimated $111K sold.

Resolute Advisors first reported a position in ZY in Q2 2022 and held it in 2 quarters. The position peaked at $111K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Resolute Advisors reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Resolute Advisors sold 40,000 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $111K.
  • Resolute Advisors first reported a position in Zymergen Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Resolute Advisors's Zymergen Inc. Common Stock position peaked at $111K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Resolute Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.